We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > droxidopa

News List

Zydus Cadila gets final nod from USFDA for Droxidopa Capsules expresspharma
February 20, 2021
Zydus Cadila has received final approval from the USFDA to market Droxidopa Capsules, 100 mg, 200 mg, and 300 mg (US RLD: Northera Capsules).
Lupin gets US FDA approval for Droxidopa Capsules expresspharma
February 20, 2021
Lupin announced that it has received approval for its Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, from the United States Food and Drug Administration, to market a generic equivalent of Northera Capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck.
Aurobindo Pharma receives USFDA nod for Droxidopa Capsules expresspharma
February 20, 2021
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Droxidopa Capsules, 100 mg, 200 mg and 300 mg. Droxidopa Capsules are generic version of Lundbeck’s Northera Capsules.
Zydus Cadila receives tentative US FDA approval for Droxidopa Capsules expresspharma
May 18, 2020
Droxidopa is used to treat symptoms of low blood pressure when standing, caused by a medical condition called neurogenic orthostatic hypotension.